Immunopharmacotherapeutic advancements in addressing methamphetamine abuse

Methamphetamine (METH) is an illicit psychostimulant that is known to account for substance abuse disorders globally, second only to opioids, yet has no approved pharmacotherapies. Traditional therapies employ small molecule agonists or antagonists for substance use disorders or overdose reversal by...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinny Claire, Janda, Kim D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341824/
https://www.ncbi.nlm.nih.gov/pubmed/34458776
http://dx.doi.org/10.1039/d0cb00165a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341824/
https://www.ncbi.nlm.nih.gov/pubmed/34458776
http://dx.doi.org/10.1039/d0cb00165a

Ejemplares similares